These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8258522)

  • 1. Integrin expression in uveal melanoma differs from cutaneous melanoma.
    ten Berge PJ; Danen EH; van Muijen GN; Jager MJ; Ruiter DJ
    Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3635-40. PubMed ID: 8258522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.
    Natali PG; Hamby CV; Felding-Habermann B; Liang B; Nicotra MR; Di Filippo F; Giannarelli D; Temponi M; Ferrone S
    Cancer Res; 1997 Apr; 57(8):1554-60. PubMed ID: 9108459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression.
    Albelda SM; Mette SA; Elder DE; Stewart R; Damjanovich L; Herlyn M; Buck CA
    Cancer Res; 1990 Oct; 50(20):6757-64. PubMed ID: 2208139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of beta-1 integrins in organ specific adhesion of melanoma cells in vitro.
    Vink J; Thomas L; Etoh T; Bruijn JA; Mihm MC; Gattoni-Celli S; Byers HR
    Lab Invest; 1993 Feb; 68(2):192-203. PubMed ID: 7680081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive and noninvasive uveal melanomas have different adhesive properties.
    Woodward JK; Rennie IG; Elshaw SR; Burn JL; Sisley K
    Eye (Lond); 2005 Mar; 19(3):342-8. PubMed ID: 15258612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.
    Nip J; Rabbani SA; Shibata HR; Brodt P
    J Clin Invest; 1995 May; 95(5):2096-103. PubMed ID: 7537755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion.
    Seftor RE; Seftor EA; Stetler-Stevenson WG; Hendrix MJ
    Cancer Res; 1993 Jul; 53(14):3411-5. PubMed ID: 7686818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential role for TGFbeta in the regulation of uveal melanoma adhesive interactions with the hepatic endothelium.
    Woodward JK; Rennie IG; Burn JL; Sisley K
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3473-7. PubMed ID: 16186321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100 immunophenotypes of uveal melanomas.
    Kan-Mitchell J; Rao N; Albert DM; Van Eldik LJ; Taylor CR
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1492-6. PubMed ID: 1696942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta1-6 branching of cell surface glycoproteins may contribute to uveal melanoma progression by up-regulating cell motility.
    Przybyło M; Pocheć E; Link-Lenczowski P; Lityńska A
    Mol Vis; 2008 Mar; 14():625-36. PubMed ID: 18385798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy.
    López MN; Pereda C; Ramírez M; Mendoza-Naranjo A; Serrano A; Ferreira A; Poblete R; Kalergis AM; Kiessling R; Salazar-Onfray F
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1219-27. PubMed ID: 17325166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on primary uveal and cutaneous melanoma cell interaction with vitronectin.
    Janik ME; Lityńska A; Przybyło M
    Cell Biol Int; 2014 Aug; 38(8):942-52. PubMed ID: 24687613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta 1 integrin expression: a marker of lymphatic metastases in cutaneous malignant melanoma.
    Hieken TJ; Ronan SG; Farolan M; Shilkaitis AL; Das Gupta TK
    Anticancer Res; 1996; 16(4B):2321-4. PubMed ID: 8694563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
    Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
    All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas.
    Ma D; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1067-75. PubMed ID: 9620065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPNMB expression in uveal melanoma: a potential for targeted therapy.
    Williams MD; Esmaeli B; Soheili A; Simantov R; Gombos DS; Bedikian AY; Hwu P
    Melanoma Res; 2010 Jun; 20(3):184-90. PubMed ID: 20375921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
    Carrel S; Schreyer M; Gross N; Zografos L
    Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.
    Zeuthen J; Birck A; Straten PT
    Arch Immunol Ther Exp (Warsz); 1995; 43(2):123-33. PubMed ID: 8744727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular role(s) for integrins in human melanoma invasion.
    Seftor RE; Seftor EA; Hendrix MJ
    Cancer Metastasis Rev; 1999; 18(3):359-75. PubMed ID: 10721490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.